Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John T Potts

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Endocrinology and Metabolism|February 6, 2009
Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshopJohn P Bilezikian, Aliya A Khan, John T Potts, et al.
The Journal of Clinical Endocrinology and Metabolism|February 6, 2009
The diagnosis and management of asymptomatic primary hyperparathyroidism revisitedAliya A Khan, John P Bilezikian, John T Potts, et al.
Molecular Endocrinology (Baltimore, Md.)|September 18, 2007
Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH/PTHrP receptorThomas Dean, Jean-Pierre Vilardaga, John T Potts, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|October 20, 2001
Commentary: clear thinking and open discussion guide IOM's report on organ donationJohn T Potts, Roger C Herdman, Thomas L Beauchamp, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|January 9, 2013
Supplement on primary hyperparathyroidismAliya A Khan, Maria Luisa Brandi, John T Potts, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 19, 2016
Prolonged Pharmacokinetic and Pharmacodynamic Actions of a Pegylated Parathyroid Hormone (1-34) Peptide FragmentJun Guo, Ashok Khatri, Akira Maeda, et al.
The Journal of Biological Chemistry|November 20, 2004
Novel parathyroid hormone (PTH) antagonists that bind to the juxtamembrane portion of the PTH/PTH-related protein receptorNaoto Shimizu, Thomas Dean, Janet C Tsang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 2008
Prolonged signaling at the parathyroid hormone receptor by peptide ligands targeted to a specific receptor conformationMakoto Okazaki, Sebastien Ferrandon, Jean-Pierre Vilardaga, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 17, 2022
The Fifth International Workshop on the Evaluation and Management of Primary HyperparathyroidismJohn P Bilezikian, Aliya A Khan, Bart L Clarke, et al.
Molecular Endocrinology (Baltimore, Md.)|December 13, 2005
Mechanisms of ligand binding to the parathyroid hormone (PTH)/PTH-related protein receptor: selectivity of a modified PTH(1-15) radioligand for GalphaS-coupled receptor conformationsThomas Dean, Agnes Linglart, Matthew J Mahon, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Endocrinology and Metabolism|February 6, 2009
Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshopJohn P Bilezikian, Aliya A Khan, John T Potts, et al.
The Journal of Clinical Endocrinology and Metabolism|February 6, 2009
The diagnosis and management of asymptomatic primary hyperparathyroidism revisitedAliya A Khan, John P Bilezikian, John T Potts, et al.
Molecular Endocrinology (Baltimore, Md.)|September 18, 2007
Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH/PTHrP receptorThomas Dean, Jean-Pierre Vilardaga, John T Potts, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|October 20, 2001
Commentary: clear thinking and open discussion guide IOM's report on organ donationJohn T Potts, Roger C Herdman, Thomas L Beauchamp, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|January 9, 2013
Supplement on primary hyperparathyroidismAliya A Khan, Maria Luisa Brandi, John T Potts, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 19, 2016
Prolonged Pharmacokinetic and Pharmacodynamic Actions of a Pegylated Parathyroid Hormone (1-34) Peptide FragmentJun Guo, Ashok Khatri, Akira Maeda, et al.
The Journal of Biological Chemistry|November 20, 2004
Novel parathyroid hormone (PTH) antagonists that bind to the juxtamembrane portion of the PTH/PTH-related protein receptorNaoto Shimizu, Thomas Dean, Janet C Tsang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 2008
Prolonged signaling at the parathyroid hormone receptor by peptide ligands targeted to a specific receptor conformationMakoto Okazaki, Sebastien Ferrandon, Jean-Pierre Vilardaga, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 17, 2022
The Fifth International Workshop on the Evaluation and Management of Primary HyperparathyroidismJohn P Bilezikian, Aliya A Khan, Bart L Clarke, et al.
Molecular Endocrinology (Baltimore, Md.)|December 13, 2005
Mechanisms of ligand binding to the parathyroid hormone (PTH)/PTH-related protein receptor: selectivity of a modified PTH(1-15) radioligand for GalphaS-coupled receptor conformationsThomas Dean, Agnes Linglart, Matthew J Mahon, et al.
Pageof 4